Equine asthma – old disease and new concepts.

Plain Language Overview

• This research article reviews the current understanding of equine asthma, a complex lung disease in horses, focusing on its underlying biological mechanisms rather than just observable symptoms.
• It highlights how studying the disease at a molecular level can lead to better diagnosis and treatment strategies tailored to individual horses.

Detailed Explanation of the Research Paper

Introduction to Equine Asthma

• Equine asthma is a common respiratory syndrome in horses characterized by airway inflammation and breathing difficulties.
• The disease has traditionally been classified based on clinical symptoms or phenotypes, like coughing and nasal discharge.
• However, similar symptoms may result from different underlying biological processes, adding complexity to diagnosis and treatment.

Molecular Endotypes and Biological Heterogeneity

• The article emphasizes the concept of molecular endotypes—subtypes of the disease defined by distinct molecular and cellular pathways rather than symptoms alone.
• This approach acknowledges that equine asthma is biologically heterogeneous, meaning multiple mechanisms can produce similar clinical outcomes.
• Identifying these endotypes allows for a more precise understanding of disease causes and progression.

Key Pathophysiological Mechanisms

• Inflammatory Pathways: The review discusses various inflammatory processes involved in equine asthma, highlighting that persistent airway inflammation is a hallmark of the disease.
• Genetic Susceptibility: Genetic factors contribute to the risk and severity of asthma, influencing how an individual horse’s immune system responds to environmental triggers.
• Airway Remodeling: Chronic inflammation leads to structural changes in the airways, such as thickening of airway walls, which perpetuate symptoms and airflow limitation.
• Neuroimmune Interactions: Emerging evidence points to complex crosstalk between the nervous and immune systems in airway inflammation, adding a new dimension to understanding disease mechanisms.

Transition From Phenotypes to Mechanism-Based Endotyping

• The paper argues for moving beyond phenotype-based classifications that group horses by observable symptoms.
• It advocates for mechanism-based endotyping, which groups horses based on underlying molecular pathways and genetic backgrounds.
• This shift aims to improve diagnostic accuracy and better tailor treatments to the specific disease mechanisms active in each horse.

Research Methodology of the Review

• The review systematically searched literature databases PubMed and Scopus using targeted keywords including “equine asthma,” “phenotypes,” “endotypes,” “genetic background,” and “neuroimmune pathophysiology.”
• A total of 146 relevant scientific publications meeting predefined selection criteria were analyzed to synthesize current evidence.

Implications for Diagnostics and Treatment

• Understanding molecular endotypes may lead to biomarker-guided diagnostics, enabling earlier and more precise identification of disease type and severity.
• Precision medicine approaches—tailoring treatments based on the horse’s specific molecular profile—could improve outcomes by targeting key inflammatory or neuroimmune pathways.
• This approach could reduce reliance on generalized treatments and improve management of chronic airway remodeling.

Conclusions and Future Directions

• The review confirms that equine asthma is a multifactorial disease involving persistent inflammation, airway structural changes, genetic predisposition, and neuroimmune signaling.
• Current clinical phenotypes offer limited insight into this complexity, underscoring the value of molecular endotyping.
• Future research and clinical practice should aim to integrate molecular and genetic information for refined disease classification and development of targeted therapies, ultimately advancing equine respiratory health.